Editor's key points † This study retrospectively analysed the incidence, clinical presentation, risk factors, and outcome of intraoperative pulmonary thromboembolism (PTE) during liver transplantation. † The incidence of intraoperative PTE was 4.0% with intraoperative and in-hospital mortalities reaching 30% and 45%. † Cardiac arrest and flat-line TEG w in triple channels 5 min after graft reperfusion were found as the most significant risk factors for developing this highly lethal complication.
adult LTs was 1.2% 6 to 6.25%. 7 Although several case series 1 6 7 and a systematic literature review 3 exist, a study of intraoperative PTE is required to manage this complication more effectively. This retrospective observational study was conducted with the hypothesis that several risk factors or diagnostic predictors for intraoperative PTE could be identified by comparing clinical characteristics between patients with and without intraoperative PTE.
Methods
The study was approved by the local institutional review board (#0307037). The requirement for written informed consent was waived by the institutional review board.
Study population
The prospectively recorded clinical data were reviewed and analysed in a retrospective fashion in adult (age .18 yr) patients who underwent isolated LT during a 3 yr period between January 1, 2004 and December 31, 2006 . The live donor LTs were excluded.
Surgical technique, anaesthetic management, and intraoperative monitoring
During the time period studied, whole liver grafts were used from deceased brain death donors and donation after cardiac death (DCD) donors. The classical piggyback method 8 with veno-venous bypass (VVB) was used for implantation.
Anaesthetic management was previously described in detail. 9 In brief, VVB was established through a 17 Fr cannula in the femoral vein and a 26 Fr cannula in the portal vein as the drainage cannula, and an 18 Fr cannula in the jugular vein as the return route. A heparin-coated bypass circuit with a centrifugal pump is connected to the cannula. Transoesophageal echocardiography (TOE) and a pulmonary artery catheter (PAC) were among the standard monitors. Packed red blood cells (PRBC) were administered to keep haematocrit between 26% and 30%. Transfusion of fresh frozen plasma (FFP), platelets, and cryoprecipitate was guided by thromboelastography (TEG w Hemostasis System 5000 Analyzer, Haemonetics Corp., Niles, IL, USA), 9 which was performed at baseline (after induction of general anaesthesia), 60 min after skin incision (I+60), 10 min in anhepatic phase (II+10), 45 min in anhepatic phase (II+45), 15 min before graft reperfusion (III215), 5, 30, and 90 min after reperfusion (III+5, III+30, and III+90). In general, no aggressive attempt was made to correct TEG abnormalities in Stages I and II. Platelet and cryoprecipitate were mainly used after 30 min of liver graft reperfusion, based on the result of TEG at III+30. If a large surgical bleeding was encountered, FFP along with PRBC was transfused using a rapid infusion system throughout the surgery. The routine mixture for the rapid infusion system was two units of FFP, two units of PRBC, and 500 ml of normal saline.
Amicar channel (with 1-aminocaproic acid) and protamine channel (with protamine sulphate) were performed at III+5 
Diagnosis of PTE, its clinical presentation, and therapy
Clinical diagnosis of PTE was made with the following criteria: (i) acute onset of systemic hypotension with elevated pulmonary arterial pressure and elevated central venous pressure from baseline, and (ii) identification of blood clots in the pulmonary artery or observation of acute right heart pressure overload (dilated right ventricle and atrium with emptied left ventricle) with or without intracardiac clots with TOE. 12 -16 'Intraoperative period' was defined as the time beginning with induction of general anaesthesia in the operating theatre and ending with admission in the intensive care unit (ICU) after LT.
Timing of PTE onset was categorized according to the three stages in LT: pre-anhepatic stage (Stage I), anhepatic stage (Stage II), and neo-hepatic stage (Stage III). 'Cardiac arrest' was defined as a clinical condition when closed chest compression or direct cardiac massage was required.
Therapeutic measures used upon the diagnosis of PTE were listed and recorded.
Outcome measures
Intraoperative death and in-hospital death (or ≤60 days after transplantation) were recorded. Patient survival and graft survival were compared between patients with intraoperative PTE and patients without intraoperative PTE, respectively.
Analysis of risk factors and diagnostic predictors of intraoperative PTE
Patients with intraoperative PTE were categorized as 'PTE group', whereas patients without intraoperative PTE formed 'non-PTE group'. Preoperative recipients' factors, donor factors, and intraoperative factors were compared between the two groups.
Preoperative recipients' factors
This data set included age, gender, BMI, the model for endstage liver disease (MELD) score, 17 
Intraoperative factors
Since the main aim in collecting data was to identify risk factors to predict intraoperative PTE, the data were only collected up to the point of diagnosis of PTE in the PTE group. For the non-PTE group, data were included in the entire intraoperative period unless otherwise indicated. Intraoperative variables included baseline pulmonary arterial pressure (before skin incision); incidence of systemic hypotension (,60 mm Hg in systolic recorded in the anaesthesia records) before the episode and diagnosis of PTE; incidence of post-reperfusion syndrome (which was defined as a sudden decrease in mean arterial pressure ≥30% for at least 1 min within the first 5 min after reperfusion of the liver graft); 20 use of inotropes vasopressors, or both; episode of clotting of the arterial blood gas (ABG) sample, which was an objective finding by the technicians in the laboratory at the time of the ABG analysis; use of i.v. heparin before VVB (2000 -3000 IU bolus administration when a normal or higher coagulation pattern was noted in TEG w in the pre-VVB period. No routine reversal with protamine sulphate was performed.); and VVB flow (litre min 21 ). Serum lactate levels were compared at baseline, at pre-graft reperfusion, and at 30 s after graft reperfusion. Serum lactate levels measured immediately before PTE diagnosis in the PTE group were compared with levels measured at the end of the transplantation in the non-PTE group. Units of transfused blood products were compared: since the amounts of blood products were only calculated before the diagnosis of PTE in the PTE group, and PTE mainly occurred within 30 min in Stage III, only blood products up to 30 min in Stage III were included in the non-PTE group.
Coagulation index (Co-I) 21 and clot lysis were compared.
Co-I (or TEG index) is calculated using a kaolin/celite-activated whole blood formula: 22 Co -I = −0.3258 × R − 0.1886 × K + 0.1224 × a + 0.0759
where R (min) is the reaction time, K (min) the time required for amplitude to reach 20 mm, a (8) the angle, and MA (mm) the maximum amplitude. Clot lysis is present when the amplitude at 30 min after MA is achieved is reduced by .8% compared with MA. 22 Of note, a 'flat line' in TEG w was defined when the a angle and MA both remained zero for more than 30 min. 23 Co-I of flat line was conservatively estimated as 227.34 (where R¼30, K¼0, a¼0, and MA¼0). The use of an antifibrinolytic agent before PTE (or up to 30 min in Stage III in the non-PTE group) was also analysed.
Statistical data analyses
Survival data were compared using the log-rank (MantelCox) test. For comparison between the PTE and non-PTE groups, categorical variables were analysed using Pearson's x 2 test or Fisher's exact test. For parametric distributing data [described in mean (SD)], unpaired Student's t-test was performed, and the Mann-Whitney U-test was performed for non-parametric distributing data (described in median with range). The level of significance was set at P,0.05. Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). Assessment of factors predictive of intraoperative PTE with univariate and multiple logistic regression analyses was performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC, USA).
Results

Study population
Among 598 isolated LTs performed in our institution, 103 patients who received live donor graft were excluded. Therefore, 495 LTs that met the inclusion criteria were identified. Three hundred and fifteen (63.6%) were males. The recipients' ages were 53.7 (11.2) yr old, with MELD scores of 21.2 (8.7). The main aetiology of liver failure was due to postnecrotic cirrhosis in 348 cases (70.3%) and cholestatic disease in 39 (7.9%). Fifty-one patients (10.3%) were in UNOS Status 1. One hundred per cent of the patients received long-term follow-up.
Incidence and clinical presentation of PTE
According to the diagnostic criteria, intraoperative PTE was found in 20 recipients (4.0%). All patients showed haemodynamic changes indicating acute right ventricular pressure overload, and intracardiac clots were observed in 17 cases (85%) with TOE. Three cases (Cases #5, #11, and #16 in 
Therapy and outcome of PTE
The therapy for PTE included haemodynamic support, including i.v. administration of epinephrine, vasopressin, norepinephrine, calcium chloride, bicarbonate, and cardiac massages if indicated. I.V. heparin was used in 14 cases (70%) upon the diagnosis of PTE, with a median dosage of 4500 IU (range 2000 -21 000 IU). Thrombolytic therapy with tissue plasminogen activator (tPA) was used in one case with the dosage of 40 mg (alteplase). No patient underwent thrombo-phlebotomy, emergency surgical thrombectomy, or extracorporeal membrane oxygenation (ECMO) support.
The incidence of intraoperative and in-hospital mortalities after PTE were 30% (six cases) and 45% (nine cases), respectively. These mortalities and graft failure rate were significantly higher than the non-PTE group (Figs 1 and 2 ).
Risk factors and diagnostic predictors for intraoperative PTE
Among preoperative recipient factors, the PTE group had an increased need for hospitalization, especially with ventilator support. The PTE group had an increased incidence of portal HTN with ascites and lower serum albumin level ( Table 2 ). None of the donor factors was found to be significantly different between the two groups (Table 3) . In terms of intraoperative factors, the PTE group had increased baseline pulmonary arterial pressures; increased incidence of haemodynamic instability (including postreperfusion syndrome, systemic hypotension, and cardiac arrest); increased incidence of clotting of ABG sample; increased level of serum lactate both in pre-reperfusion and before PTE diagnosis (PTE group) vs end of transplantation in the non-PTE group. The PTE group required more PRBC and FFP, but less platelet.
Baseline Co-I and incidence of lysis at baseline were similar between the groups; however, in the PTE group, Co-I became markedly decreased at III+5 and incidence of lysis was increased. Accordingly, the use of low-dose antifibrinolytics was greater in the PTE group. The incidence of flat TEG w in native channel, and the other two channels (amicar and protamine), was significantly increased, especially at III+5, in the PTE group (Table 4) . Table 5 lists all significant risk factors and diagnostic predictors in univariate logistic regression analysis. No formal multiple logistic regression was performed in order to avoid over-fitting and false-positive results. 24 Cardiac arrest and flat-line TEG w in the three channels at III+5 were the most significant risk factors or diagnostic predictors for PTE.
Discussion
This retrospective analysis was conducted to characterize intraoperative PTE occurring in adult patients undergoing LT. Four conclusions from our data analysis merit comment.
First, the incidence of intraoperative PTE was 4.0%, which is similar to reported incidence of PTE. 1 6 7 25 To evaluate the incidence of PTE, the method of diagnosis is critically important. In our study, diagnostic criteria of PTE were the combination of haemodynamic compromise and TOE findings. In the TOE evaluation, not only the primary finding (identification of the clots in the pulmonary arterial trees), but also the secondary findings (the right-sided heart volume and pressure strain pattern; and/or clot in the right cardiac chambers) were used. Since the latter findings are considered sufficient for diagnosing acute PTE, 12 -15 three cases without clot identification were included in the PTE group. Of note, diagnostic methods used in the literature for PTE during LT were heterogeneous, including TOE in 39 patients, typical signs and the clinical course without TOE in seven cases, autopsy findings in 18 patients, and unclarified methods in nine patients. 3 Secondly, intraoperative and in-hospital mortalities after PTE reached 30% and 45%, respectively, which was comparable with the other case series. 6 7 Upon the diagnosis of PTE, i.v. heparin was administered in 14 cases (70%), whereas tPA was used in only one case. 26 27 Indication for invasive therapeutic measures would depend on the severity and the length of haemodynamic compromise, since spontaneous resolution of the clots was often found within 30 min of the clinical onset. 6 Several successful outcomes were reported with ECMO or cardiopulmonary bypass, 28 29 or Thirdly, we identified the risk factors or diagnostic predictors for intraoperative PTE, including haemodynamic abnormalities and TEG w findings (flat line and lysis). Hypotension with the mean arterial pressure ,40 mm Hg at least once during LT was associated with negative surgical outcome with the odds ratio of 2.39 in the retrospective review of 789 LTs. 32 The latter TEG w findings are intriguing, since previous studies showed that patients with PTE had 'hypercoagulable condition', which was suggested with blood sample clotting 6 30 or with a marked decrease in antithrombin-III. 30 In our study, hypercoagulable status (Co-I.3) was not identified as the risk factor. The mechanism of flat-line TEG w has not been well defined, although it is occasionally found after graft reperfusion.
1 It was considered due to (i) decreased coagulation factors, (ii) heparin -heparinoid effect, (iii) severe fibrinolysis, 1 or any of the combination of these. 23 Our finding suggests that flat-line TEG w should not naively be interpreted as a 'hypocoagulable' state. Instead, it could indicate the existence of massive activation of the fibrinolytic system which was initiated by clot formation in venous system, or it could demonstrate the potential of disseminated intravascular coagulation (DIC)-like condition, which could result in PTE. 23 In the former case, flat-line TEG is a sign of ongoing process of PTE, while the latter process indicates that the flat-line TEG is a predisposing risk factor for PTE. We do not have the data to differentiate these with the data available; however, flat-line TEG has a diagnostic or predictive value of PTE. Furthermore, based on these two categories of risk factors found in this study, the following hypothesis can be made as a potential mechanism of PTE during LT; a haemodynamic compromise initiates stasis of the venous blood with a potential of DIC. It then forms thrombin/platelet aggregate in situ 33 on the endothelial surface of pulmonary arteries/capillaries, on the endocardial surface of the right-sided heart chambers, or on the non-biocompatible surface of central venous lines. 26 The process progresses to form intracardiac, pulmonary arterial clots, or both, which lead to PTE. This hypothesis matches the Virchow triad. 34 A traditional mechanism of PTE due to pre-existing DVT of the extremities may not explain the majority of PTEs occurring during LT. Fourthly, many of the putative risk factors proposed in the past were not identified in our study, including sepsis, DIC, 2 35 TIPS, 36 and hepatitis B immunoglobulin. 2 Transfusion requirements of PRBC and FFP 31 33 were identified as significant but weak risk factors. Platelet transfusion turned out that the PTE group had significantly less units transfused compared with the non-PTE group. This finding is needed to be cautiously interpreted. In our protocol, platelet transfusion was generally indicated by the TEG result at 30 min after reperfusion. No attempt was generally made to provide platelet before re-perfusion of the graft. The transfusion units of platelets appeared to be lower for the PTE group compared with those for the non-PTE group due, at least in part, to the higher incidence of death within 30 min after reperfusion in the PTE group. It is more likely that the association between platelet transfusion and mortality has to be taken as a survival bias rather than a survival benefit. 37 The use of a PAC has been considered as a putative risk factor; 26 33 however, its effect could not be evaluated in this study since a PAC was one of the standard monitoring devices. The most controversial potential risk factors (VVB 1 2 6 26 28 31 35 38 39 and prophylactic anti-fibrinolytic agents) 28 31 35 38 could not be examined, since VVB was routinely established and the prophylactic high-dose antifibrinolytic agents were not used. VVB was originally proposed to minimize the venous stasis; 40 however, it was often suggested as a potential risk factor, due to the temporal relationship of simultaneous occlusion of bypass circuit and occurrence of PTE 30 39 and theoretical risk of activation of the coagulation system. 41 In our own older cohort between 2001 and 2003, the PTE was found in 1.4% (six in 426 LTs), with four cases with retro-caval resection with VVB, one case with piggyback with VVB, and one case with piggyback without VVB. 25 At least, there was no significant difference in the incidence based on the various surgical methods (with or without the use of VVB). Anti-fibrinolytic agents had been suggested as the potential risk factors for PTE; however, a recent meta-analysis did not support it.
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Several important limitations exist. First, a retrospective nature of the study carries an intrinsic risk of difficulty of determining the true incidence of PTE, which could partially explain a difference observed in the current incidence (4.0%, 20 in 495 LTs in 2004 -6) compared with that from the older cohort in our institution (1.4%, six in 426 LTs in 2001 -3). 25 The difference might also attribute to detection bias due to the difference in focus between the two studies and might associate with changes made in transplantation practice between the two periods. Secondly, this study does With 20 PTE cases (events), we probably could fit at most two valid predictors in a multivariable logistic model. Considering the multiple risk factors and diagnostic predictors we identified, to select a single best model without worrying about over-fitting and false-positive results becomes considerably more difficult. Fourthly, we did not identify potential risk factors which could be modified to potentially reduce the incidence of PTE. The significantly increased incidence of cardiac arrest and flat-line TEG w in the PTE group should be considered as the diagnostic predictors rather than the risk factors of PTE. However, we believe that each factor has its importance. Regarding cardiac arrest, high likelihood of PTE associated with this haemodynamic catastrophe should prompt immediate evaluation of the cardiac chamber with TOE, since intraoperative diagnosis of PTE is only confirmed with this modality. This finding strongly indicates the importance of availability of TOE and expertise of its use in LT practice, which are not universally available yet. 42 Regarding flat-line TEG w , it should be a useful warning sign for existing PTE. This new finding also indicates the potential usefulness of developing a more rapid and specific diagnostic coagulation monitoring.
In conclusion, this retrospective review of 495 adult isolated LTs showed a PTE incidence of 4.0% (20 cases), with an intraoperative mortality rate of 30% and an in-hospital mortality rate of 45%. Cardiac arrest and flat-line TEG w in triple channels 5 min after graft reperfusion were found as the most significant risk factors for developing this highly lethal complication. Table 5 Risk factors or diagnostic predictors for PTE. For binary risk factor, odds ratio represents the odds of developing PTE for a patient with risk factor (yes) vs the odds for a patient without risk factor (no). For continuous risk factor, for a one-unit increase in the risk factor in a patient, we expect to see (odds ratio21)×100% increase (or decrease if negative) in the odds of developing PTE. This increase (or decrease) does not depend on the value that the current risk factor is held at. A rough guideline for interpretation of AUC: 0.50 -0.75¼fair, 0.75 -0.92¼good, 0.92 -0.97¼very good, and 0.97 -1.00¼excellent. *Flat TEG findings in all three channels (natural, amicar, and protamine). ‡ TEG in the natural channel was flat at any time of the transplantation. § 'Hypotension' is defined as the systemic arterial systolic pressure below 60 mm Hg for more than 1 min.
‡ ‡ Blood transfusions were compared using the units transfused before the diagnosis of PTE and those up to 30 min after graft reperfusion in the non-PTE group. AUC, area under the receiver operating characteristic curve; SE, standard error; 95% CI, 95% confidence interval; TEG, thromboelastography; III+5, 5 min after graft reperfusion; PRS, post-reperfusion syndrome; LT, liver transplantation; HTN, hypertension; PAD, diastolic pulmonary arterial pressure; PAS, systolic pulmonary arterial pressure; PRBC, packed red blood cells; FFP, fresh frozen plasma; WIT, warm ischaemic time; Co-I, coagulation index 
